Mevalonic acid lithium salt [2618458-93-6]
Référence NB-64-74902-1ml
Conditionnement : 1mLx10mM(inDMSO)
Marque : Neo Biotech
Mevalonic acid lithium salt (Synonyms: MVA lithium salt)
Catalog No. T19426 Copy Product Info
Purity: 98%
Mevalonic acid lithium salt (MVA lithium salt) is a precursor of the mevalonic acid pathway, an initiator of cell growth, a key substance in cholesterol synthesis, and stimulates DNA synthesis, morphology transformation, and cell cycling in human lymphocytes from peripheral blood.
Mevalonic acid lithium salt
Copy Product InfoSynonyms MVA lithium salt
Mevalonic acid lithium salt (MVA lithium salt) is a precursor of the mevalonic acid pathway, an initiator of cell growth, a key substance in cholesterol synthesis, and stimulates DNA synthesis, morphology transformation, and cell cycling in human lymphocytes from peripheral blood.
Cas No. 2618458-93-6
Select Batch
Purity:98%
Appearance:Solid
Color:White
Contact us for more batch information
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | Mevalonic acid lithium salt (MVA lithium salt) is a precursor of the mevalonic acid pathway, an initiator of cell growth, a key substance in cholesterol synthesis, and stimulates DNA synthesis, morphology transformation, and cell cycling in human lymphocytes from peripheral blood. |
| In vitro | Mevalonic acid lithium salt (80, 90, 100, 110 µM) treatment of C2C12 myotubular cells for 72 hours resisted simvastatin-induced reduction in cell viability. [1] |
| Synonyms | MVA lithium salt |
| Molecular Weight | 154.09 |
| Formula | C6H11LiO4 |
| Cas No. | 2618458-93-6 |
| Smiles | O=C(CC(C)(CCO)O)[O-].[Li+] |
| Relative Density. | no data available |
| Storage | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 40 mg/mL (259.59 mM), Sonication is recommended. H2O: 80 mg/mL (519.18 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (12.98 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO/H2O
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||
Vous serez peut-être également intéressé par les produits suivants :
Référence
Description
Cond.
Prix HT